A strong drug pipeline could boost shares of Ionis Pharmaceuticals in the future, JPMorgan says. Analyst Jessica Fye upgraded the biotech company, which develops human therapeutic...
Brinker International shares gained more than 2% after JPMorgan raised its rating on the Chili’s parent thanks to an attractive valuation. The bank upgraded the stock...
